Literature DB >> 21121285

Preferential killing of cancer cells using silicon carbide quantum dots.

Barbara Mognetti1, Alessandro Barberis, Silvia Marino, Francesco Di Carlo, Vladimir Lysenko, Olivier Marty, Alain Géloën.   

Abstract

Silicon carbide quantum dots are highly luminescent biocompatible nanoparticles whose properties might be of particular interest for biomedical applications. In this study we investigated Silicon Carbide Quantum Dots (3C-SiC QDs) cellular localisation and influence on viability and proliferation on oral squamous carcinoma (AT-84 and HSC) and immortalized cell lines (S-G). They clearly localize into the nuclei, but the presence of 3C-SiC QDs in culture medium provoke morphological changes in cultured cells. We demonstrate that 3C-SiC QDs display dose- and time-dependent selective cytotoxicity on cancer versus immortalized cells in vitro. Since one of the limitations of classical antineoplastic drugs is their lack of selectivity, these results open a new way in the search for antiproliferative drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121285     DOI: 10.1166/jnn.2010.3049

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  3 in total

Review 1.  The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.

Authors:  S Jeelani; G S Asokan; G Anuradha; J Parthiban; T Sivasankari
Journal:  J Clin Diagn Res       Date:  2014-07-20

2.  Vapor phase mediated cellular uptake of sub 5 nm nanoparticles.

Authors:  Tetiana Serdiuk; Vladimir Lysenko; Valery A Skryshevsky; Alain Géloën
Journal:  Nanoscale Res Lett       Date:  2012-04-11       Impact factor: 4.703

3.  Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors.

Authors:  Francesca Bertolini; Giulia Casarotti; Luisella Righi; Enrico Bollito; Carlo Albera; Silvia Anna Racca; Donato Colangelo; Barbara Mognetti
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.